Colecalciferol/risedronic acid - Daewoong
Alternative Names: IMD 7; Incrementally modified drug 7; Risen Plus TabletLatest Information Update: 27 Jun 2019
At a glance
- Originator Daewoong Pharmaceutical
- Class Adjuvants; Bisphosphonates; Calcium regulators; Cholestenes; Osteoporosis therapies; Small molecules; Sterols; Vitamin D analogues
- Mechanism of Action Bone resorption factor inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoporosis
Most Recent Events
- 27 Jun 2019 Chemical structure information added
- 18 Jun 2013 Launched for Osteoporosis in South Korea (PO)